U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07177950) titled 'A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases' on Sept. 02.
Brief Summary: This is a multi-center, open-label, two-cohort study. The purpose of this study is to evaluate the safety, tolerability and efficacy of SHR-A1811 in the treatment of HER2-positive breast cancer with brain and leptomeningeal metastases, and the efficacy and safety of SHR-A1811 in the treatment of HER2-positive breast cancer with brain but without leptomeningeal metastases.
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Brain Metastases
Leptomeningeal Metastasis
Interv...